<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001428'>Somatic mutation</z:hpo> (SM) analysis provides a useful tool for understanding the stages at which neoplastic differentiate from <z:mpath ids='MPATH_458'>normal</z:mpath> B-cells </plain></SENT>
<SENT sid="1" pm="."><plain>B-cell precursor <z:hpo ids='HP_0002664'>neoplasms</z:hpo> are considered to be somatically premutational </plain></SENT>
<SENT sid="2" pm="."><plain>However, the variable frequency of SM of the variable region (VH) genes has been described in cases of precursor B-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (PB-ALL) </plain></SENT>
<SENT sid="3" pm="."><plain>To better characterize PB-ALL based on the differentiation stage, we investigated the SM of the VH genes expressed by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells of the surface immunoglobulin (sIg)(-) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-3 cell line derived from childhood PB-ALL </plain></SENT>
<SENT sid="4" pm="."><plain>In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-3 cell line, the rearranged Ig heavy chain VH gene sequence showed no SM in the complementarity-determining regions of 1, 2, and 3, or in the framework regions of 1, 2, and 3 relative to the putative germline VH gene sequences </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, the VH segment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-3 cells showed no intraclonal sequence <z:hpo ids='HP_0001425'>heterogeneity</z:hpo>, indicating ongoing SM </plain></SENT>
<SENT sid="6" pm="."><plain>Our data demonstrated that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-3 cells express unmutated and developmentally regulated rearrangement of VH genes at the stage of B-cell precursor cells </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HBL</z:e>-3 cells, which are derived only from the sIg(-) PB-ALL, showed that SM cannot be recognized in VH genes of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells before the expression of sIg </plain></SENT>
</text></document>